Nanjing Well Pharmaceutical Group Co. Ltd. Class ASSE: 603351

Announcement on Convening Performance Briefing for 2025 and Q1 2026

Apr 28, 2026 · Issued by Nanjing Well Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Nanjing Well Pharmaceutical Group Co. Ltd. Class A

Announcement on Result of Shareholding Reduction by Shareholder through Call AuctionApr 14
Announcement on Pledge Extension of Shares Held by Shareholder with Over 5% SharesMar 26
Announcement on Pledge of Shares Held by Shareholder with Over 5% SharesMar 18
Announcement on Plan of Shareholding Reduction by Shareholders through Call AuctionFeb 27

All Nanjing Well Pharmaceutical Group Co. Ltd. Class A news releases